Literature DB >> 12477649

Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology.

José Placer1, Blanca Espinet, Marta Salido, Francesc Solé, Antoni Gelabert-Mas.   

Abstract

OBJECTIVES: To evaluate the clinical utility of a Multi-color FISH (fluorescence in situ hybridization) assay in voided urine specimens for the detection of bladder cancer and its recurrences, comparing the results with those afforded by urinary cytology.
METHODS: Voided urine samples from 86 patients were obtained for urine cytology and FISH analysis. The latter was performed using a mixture of fluorescent labeled DNA probes for the centromeric regions of chromosomes 3, 7 and 17, and the 9p21 region. Cystoscopy with biopsy or tumor resection was performed in all patients, comparing the pathological results with the cytological and FISH findings.
RESULTS: Urinary cytology affords an overall sensitivity of 63.8%, the figure being 25% for grade 1, 66.6% for grade 2 and 94.7% for grade 3 tumors. The sensitivities for FISH were 53.3% for grade 1, 83.3% for grade 2 and 100% for grade 3 tumors, with an overall sensitivity of 80.4%. The specificities of urinary cytology and FISH were 86.1 and 85.3%, respectively.
CONCLUSIONS: FISH improves the sensitivity rates obtained with urine cytology for bladder cancer detection in all tumor grades and stages, and offers similar specificity. FISH doubles the accuracy of urinary cytology in application to low grade-stage tumors, and detects all high grade infiltrating tumors.

Entities:  

Mesh:

Year:  2002        PMID: 12477649     DOI: 10.1016/s0302-2838(02)00448-7

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  12 in total

1.  The value of the preoperative FISH test in unscreened bladder cancer patients with TUR indications.

Authors:  S V Petrov; K A Malkhasyan; M Yu Ulyanin; E F Abdrakhmanov; R Sh Khasanov
Journal:  Pathol Oncol Res       Date:  2012-06-23       Impact factor: 3.201

2.  Urine cytology and adjunct markers for detection and surveillance of bladder cancer.

Authors:  Peggy S Sullivan; Jessica B Chan; Mary R Levin; Jianyu Rao
Journal:  Am J Transl Res       Date:  2010-07-25       Impact factor: 4.060

3.  The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer.

Authors:  Mario I Fernández; Sahil Parikh; H Barton Grossman; Ruth Katz; Surena F Matin; Colin P N Dinney; Ashish M Kamat
Journal:  Urol Oncol       Date:  2011-03-10       Impact factor: 3.498

4.  Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study.

Authors:  Nancy P Caraway; Abha Khanna; Ricardo L Fernandez; Linda Payne; Roland L Bassett; Hua-Zhong Zhang; Ashish Kamat; Ruth L Katz
Journal:  Cancer Cytopathol       Date:  2010-10-25       Impact factor: 5.284

5.  [Secondary prevention after urological tumor diseases. Focusing on the kidneys, testes, and bladder].

Authors:  M J Mathers; D A Lazica; T Klotz; F Sommer; S Roth
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

Review 6.  Urinary markers in screening patients with hematuria.

Authors:  Edmund Chiong; Kris E Gaston; H Barton Grossman
Journal:  World J Urol       Date:  2007-12-04       Impact factor: 4.226

7.  SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer.

Authors:  Changhao Chen; Hanhao Zheng; Yuming Luo; Yao Kong; Mingjie An; Yuting Li; Wang He; Bowen Gao; Yue Zhao; Hao Huang; Jian Huang; Tianxin Lin
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

8.  The utility of fluorescence in situ hybridization for detection of bladder urothelial carcinoma in routine clinical practice.

Authors:  Kyung Won Kwak; Sun Hee Kim; Hyun Moo Lee
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

9.  UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study.

Authors:  Yavuz Dodurga; Cığır Biray Avcı; Sunde Yılmaz; Oktay Nazlı; Ozgür Coğulu; Tufan Cankaya; Cumhur Gündüz
Journal:  Contemp Oncol (Pozn)       Date:  2013-04-29

10.  Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood.

Authors:  Angela A G van Tilborg; Lucie C Kompier; Irene Lurkin; Ricardo Poort; Samira El Bouazzaoui; Kirstin van der Keur; Tahlita Zuiverloon; Lars Dyrskjot; Torben F Orntoft; Monique J Roobol; Ellen C Zwarthoff
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.